<DOC>
	<DOCNO>NCT00713154</DOCNO>
	<brief_summary>The purpose study determine MTS-01 effective prevent radiotherapy-induced hair loss patient receive whole brain radiotherapy</brief_summary>
	<brief_title>Safety Preliminary Efficacy Study MTS-01 Prevention Alopecia Induced WHole Brain Radiotherapy</brief_title>
	<detailed_description>Hair loss ( alopecia ) occur commonly result external beam radiotherapy brain , contribute social isolation distress patient cancer . MTS-01 topical gel formulation apply scalp delivery radiotherapy</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Tempol</mesh_term>
	<criteria>&gt; /= 18 year age Has metastatic cancer brain palliative prophylactic whole brain radiotherapy recommend . A histological diagnosis cancer require , however , biopsy brain metastasis require Can understand sign IRB/IEC approve informed consent , communicate Investigator , understand requirement protocol sign HIPAA authorization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>induced</keyword>
</DOC>